Amphetamine

1. 2026-10-19issueIssued info_card
2. 2026-09-27runbrief run
3. 2026-09-27revisionr1.a1
4. 2026-09-24srcPrescription Stimulant Use, Misuse, and Use Disorder Among US Adults Aged 18 to 64 Years
5. 2026-09-24srcComparative pharmacology and abuse potential of oral dexamphetamine and lisdexamfetamine: A literature review
6. 2026-09-24srcEffect of d-amphetamine on post-error slowing in healthy volunteers
7. 2026-09-24srcEffects of amphetamine on reactivity to emotional stimuli
8. 2026-09-24srcPharmacological Treatment of ADHD During Pregnancy and Lactation
9. 2026-09-24srcAntipsychotics for the treatment of sympathomimetic toxicity: A systematic review
10. 2026-09-24srcTranylcypromine in mind (Part I): Review of pharmacology
11. 2026-09-24srcHow effective are pharmaceuticals for cognitive enhancement in healthy adults? A series of meta-analyses of cognitive performance during acute administration of modafinil, methylphenidate and D-amphetamine
12. 2026-09-24srcUpdate on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications
13. 2026-09-24srcComparative efficacy and tolerability of medications for ADHD in children, adolescents, and adults: a systematic review and network meta-analysis
14. 2026-09-24srcOverview of the treatment of binge eating disorder
15. 2026-09-24srcExploring the determinants of TAAR1 functional selectivity for the stereoisomers of amphetamine and methamphetamine
16. 2026-09-24srcAttention-deficit/hyperactivity disorder
17. 2026-09-24srcOn the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D2/3 receptor agonist radioligand study
18. 2026-09-24srcDifferential dopamine release by psychosis-generating and non-psychosis-generating addictive substances in nucleus accumbens and dorsomedial striatum
19. 2026-09-24srcAdderall (amphetamine-dextroamphetamine) toxicity
20. 2026-09-24srcAddiction in pregnancy
21. 2026-09-24srcThe Clinical Pharmacokinetics of Amphetamines Utilized in the Treatment of Attention-Deficit/Hyperactivity Disorder
22. 2026-09-24srcIn Vitro Characterization of Psychoactive Substances at Rat, Mouse, and Human Trace Amine-Associated Receptor 1
23. 2026-09-24srcImpact of dextroamphetamine substitution on the use of illicit amphetamines in adults with amphetamine dependence: ATLAS4Dependence trial protocol
24. 2026-09-24srcMethamphetamine Use and Cardiovascular Disease
25. 2026-09-24srcEvidence-based consensus guidelines for the pharmacological management of substance dependence: Recommendations from the British Association for Psychopharmacology
26. 2026-09-24srcA Single-Dose, Two-Way Crossover, Open-Label Bioequivalence Study of an Amphetamine Extended-Release Oral Suspension in Healthy Adults
27. 2026-09-24srcMechanisms of Amphetamine Action Revealed in Mice Lacking the Dopamine Transporter
28. 2026-09-24srcMethamphetamine-Induced Degeneration of Dopaminergic Neurons Involves Autophagy and Upregulation of Dopamine Synthesis
29. 2026-09-24srcThe pharmacology and clinical outcomes of amphetamines to treat ADHD: does composition matter?
30. 2026-09-24srcLong-Lasting Epigenetic Changes in the Dopamine Transporter in Adult Animals Exposed to Amphetamine during Embryogenesis
31. 2026-09-24srcIschemic cardiomyopathy in a 43-year-old male with stroke: role of chronic amphetamine-dextroamphetamine use
32. 2026-09-24srcAmphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin
33. 2026-09-24srcSLI381 (Adderall XR), a two-component, extended-release formulation of mixed amphetamine salts: bioavailability of three test formulations
34. 2026-09-24srcCardiovascular manifestations of substance abuse: part 2: alcohol, amphetamines, heroin, cannabis, and caffeine
35. 2026-09-24srcClinical pharmacokinetics of amfetamine and related substances
36. 2026-09-24srcNoradrenergic and dopaminergic effects of (+)-amphetamine-like stimulants in the baboon Papio anubis
37. 2026-09-24srcCerebrovascular and cardiovascular complications of alcohol and sympathomimetic drug abuse
38. 2026-09-24srcLong-term cardiovascular effects of mixed amphetamine salts extended release in adults with ADHD
39. 2026-09-24srcTherapeutic potential of monoamine transporter substrates
40. 2026-09-24srcNew insights into the mechanism of action of amphetamines
41. 2026-09-24srcLiking, wanting, and the incentive-sensitization theory of addiction
42. 2026-09-24srcEnduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis
43. 2026-09-24srcBrain dopamine and amphetamine-induced stereotyped behaviour
44. 2026-09-24srcMultiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants
45. 2026-09-24srcAmphetamine Legal Status and History
46. 2026-09-24srcAmphetamine - Discovery and History
47. 2026-09-04issueIssued emergency
48. 2026-09-04issueIssued info_card
49. 2026-09-04issueIssued notice
50. 2026-06-04proposal38 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
51. 2026-06-04publicationPublication — backfill
52. 2026-04-24revisionRevision 1
53. 2026-04-24genGeneration — pipeline-v5 · with 2 morepipeline-v5
54. 2026-04-24rungeneration run

The same entries, as forms: six forms.